I'd like to cancel this standing order risperdal urup fiyat Most recently in July, Vertex Pharmaceuticals Inc,which already sells the market-leading hepatitis C treatmentIncivek, said U.S. health regulators placed a partial clinicalhold on a mid-stage study of its experimental oral hepatitis Ctreatment, VX-135, because of potential liver problems.
|